Yüklüyor......
Targeting the heparin-binding domain of fibroblast growth factor receptor 1 as a potential cancer therapy
BACKGROUND: Aberrant activation of fibroblast growth factor receptors (FGFRs) deregulates cell proliferation and promotes cell survival, and may predispose to tumorigenesis. Therefore, selective inactivation of FGFRs is an important strategy for cancer therapy. Here as a proof-of-concept study, we d...
Kaydedildi:
| Yayımlandı: | Mol Cancer |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioMed Central
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4511971/ https://ncbi.nlm.nih.gov/pubmed/26201468 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12943-015-0391-4 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|